CEO Pfizer sells shares after vaccine rally | Financial

Market Insider reports that Bourla averaged $ 41.94 per share, or 15% more than the day-earlier closing price and close to its highest level this year. Meanwhile, the price has fallen to around $ 38.40. With his package of 132,508 shares, the CEO raised $ 5.6 million.

The sale was already planned in August, according to a document. Pfizer confirms that it is a policy for major shareholders and insiders to pass on orders for execution at a later date.

–